Cargando…

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes

Systemic sclerosis (SSc) is characterized by the presence of SSc-specific or SSc-associated antibodies (SSc-Abs): anti-topoisomerase I (ATA), anti-centromere (ACA), anti-RNA polymerase III (ARA), anti-U3RNP (U3RNP), anti-U1RNP (U1RNP), anti-PmScl (PmScl), anti-Ku (Ku) and anti-Th/To (Th/To), each be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Kristina E. N., Campochiaro, Corrado, Host, Lauren V., Sari, Alper, Harvey, Jennifer, Denton, Christopher P., Ong, Voon H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250530/ https://www.ncbi.nlm.nih.gov/pubmed/35780179 http://dx.doi.org/10.1038/s41598-022-15062-4

Ejemplares similares

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2014)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Clinical phenotype in scleroderma patients based on autoantibodies
por: Santos, Cristiana Sieiro, et al.
Publicado: (2023)

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
por: Caetano, Joana, et al.
Publicado: (2018)

The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)

Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups
por: Clark, Kristina Elizabeth Neergaard, et al.
Publicado: (2023)

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
por: Raschi, Elena, et al.
Publicado: (2018)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
por: Betteridge, Zoe E., et al.
Publicado: (2018)

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020)

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature
por: Derrett-Smith, Emma C., et al.
Publicado: (2017)

Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study
por: Clark, Kristina E N, et al.
Publicado: (2022)

Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints
por: Marketos, Nikolaos, et al.
Publicado: (2023)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

What autoantibody tests should become widely available to help scleroderma diagnosis and management?
por: Muro, Yoshinao, et al.
Publicado: (2013)

Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022)

The Hallmarks of Cancer as Ecologically Driven Phenotypes
por: Somarelli, Jason A.
Publicado: (2021)

Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients
Publicado: (1981)

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
por: Gilbane, Adrian J, et al.
Publicado: (2013)

Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes
Publicado: (1992)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019)

Scleroderma
Publicado: (1890)

Potential Methods of Targeting Cellular Aging Hallmarks to Reverse Osteoarthritic Phenotype of Chondrocytes
por: He, Yuchen, et al.
Publicado: (2022)

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis
por: Cantanhede, Isabella Gomes, et al.
Publicado: (2022)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
por: Macklin, Michael, et al.
Publicado: (2023)

Distinct metabolic hallmarks of WHO classified adult glioma subtypes
por: Björkblom, Benny, et al.
Publicado: (2022)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients
por: Morozzi, Gabriella, et al.
Publicado: (2011)

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
por: Gourh, Pravitt, et al.
Publicado: (2020)

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
por: Raschi, Elena, et al.
Publicado: (2020)

Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
por: Fleming, Jo N., et al.
Publicado: (2008)

Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
por: Rossi, Antonella, et al.
Publicado: (2010)

Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
por: Lazic, Andrijana, et al.
Publicado: (2022)

Keloids in Scleroderma-Keloidal Scleroderma: A Unique Entity
por: Sen, Sumit, et al.
Publicado: (2013)

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma
por: Derrett-Smith, Emma C, et al.
Publicado: (2010)

Hand disease in scleroderma: a clinical correlate for chronic hand transplant rejection
por: Amin, Kavit, et al.
Publicado: (2013)

Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features
por: Mierau, Rudolf, et al.
Publicado: (2011)

Case of Scleroderma
por: Lucas,
Publicado: (1877)

Phototherapy in Scleroderma
por: Hassani, John, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_85jtsl73k4tnngqir709indoqu